What is the official website of Adelphi Group ?

The official website of Adelphi Group is http://www.adelphigroup.com.

What is Adelphi Group's cybersecurity risk score?

Adelphi Group has an AI-generated cybersecurity risk score of 754 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Adelphi Group experienced?

According to Rankiteo, Adelphi Group currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Adelphi Group been affected by any supply chain cyber incidents ?

According to Rankiteo, Adelphi Group has been affected by a supply chain cyber incident involving Snowflake, with the incident ID ATT1764820523.

Does Adelphi Group have SOC 2 Type 1 certification ?

According to Rankiteo, Adelphi Group is not certified under SOC 2 Type 1.

Does Adelphi Group have SOC 2 Type 2 certification ?

According to Rankiteo, Adelphi Group does not hold a SOC 2 Type 2 certification.

Does Adelphi Group comply with GDPR ?

According to Rankiteo, Adelphi Group is not listed as GDPR compliant.

Does Adelphi Group have PCI DSS certification ?

According to Rankiteo, Adelphi Group does not currently maintain PCI DSS compliance.

Does Adelphi Group comply with HIPAA ?

According to Rankiteo, Adelphi Group is not compliant with HIPAA regulations.

Does Adelphi Group have ISO 27001 certification ?

According to Rankiteo,Adelphi Group is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Adelphi Group operate in ?

Adelphi Group operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Adelphi Group have ?

Adelphi Group employs approximately 258 people worldwide.

Does Adelphi Group own any subsidiaries ?

Adelphi Group presently has no subsidiaries across any sectors.

How many LinkedIn followers does Adelphi Group have ?

Adelphi Group's official LinkedIn profile has approximately 7,326 followers.

What is the NAICS classification code for Adelphi Group ?

Adelphi Group is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Adelphi Group have a Crunchbase profile ?

No, Adelphi Group does not have a profile on Crunchbase.

Does Adelphi Group have a LinkedIn profile ?

Yes, Adelphi Group maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/adelphi-group.

How many cybersecurity incidents has Adelphi Group experienced ?

As of September 24, 2026, Rankiteo reports that Adelphi Group has experienced 1 cybersecurity incidents.

How many peer or competitor companies does Adelphi Group have ?

Adelphi Group has an estimated 5,769 peer or competitor companies worldwide.

What types of cybersecurity incidents has Adelphi Group faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Breach.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Adelphi Group

Boost Score +25 with badge (5 left)

754

/1000

Fair

779

/1000

Fair

Adelphi Group Vendor Cyber Rating & Cyber Score

adelphigroup.com

Add Your Compliance Badge

The Adelphi Group provides a wide range of strategic support services and consulting for global pharmaceutical clients. Adelphi is dedicated to the healthcare sector, providing services across strategic marketing, marketing and business intelligence, real-world observational research and disease-specific programmes, health and economic outcomes, market access, pricing and reimbursement, value insight, multi-channel health communications, scientific services, medical education, and strategic product development consultancy. Headquarters are located in Manchester, UK and New York with network offices throughout Europe and the US. The Adelphi Group employs over 700 people worldwide.

Adelphi Group

Adelphi Group CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

Omnicom

Breach

1/2024

Snowflake

ATT1764820523

Loading…

A.I.

Adelphi Group Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Adelphi Group

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Adelphi Group in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Adelphi Group in 2026.

Incident Types Adelphi Group vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Adelphi Group in 2026.

Incident History - Adelphi Group (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Adelphi Group Subsidiaries

Adelphi Group

Pharmaceutical Manufacturing

Website: http://www.adelphigroup.com

Company Size: 258

Omnicom HealthMarketing Services

Healthcare Consultancy Group - HCGAdvertising Services

BioluminaAdvertising Services

OmnicomAdvertising Services

Omnicom AdvertisingAdvertising Services

FlywheelAdvertising Services

Omnicom ProductionAdvertising Services

Omnicom PR Group (OPRG)Public Relations and Communications Services

Omnicom Precision Marketing GroupAdvertising Services

Omnicom Specialty Marketing GroupAdvertising Services

Harrison/StarAdvertising Services

DDB Health New YorkAdvertising Services

2TN (2 the Nth)Pharmaceutical Manufacturing

Ology Medical EducationWellness and Fitness Services

Adelphi AccessPharmaceutical Manufacturing

DDB Remedy LondonAdvertising Services

Archbow ConsultingPharmaceutical Manufacturing

The Planning ShopAdvertising Services

Excerpta Medica BV - Adelphi GroupPharmaceutical Manufacturing

Adelphi Real WorldBusiness Consulting and Services

Science & PurposeAdvertising Services

MCIMarket Research

DDB Health BarcelonaAdvertising Services

cdmpAdvertising Services

SSCG Media GroupAdvertising Services

Addressable HealthAdvertising Services

Wildtype HealthAdvertising Services

PROPELLERAdvertising Services

BioPharm CommunicationsAdvertising Services

Expert Perspectives by Engage Health MediaPharmaceutical Manufacturing

TBWA\WORLDHEALTHAdvertising Services

CDM BarcelonaAdvertising Services

Loading…

Adelphi Group Similar Companies

MSD

msd.com

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.msd.com and connect with us on Facebook, Instagram, Twitter, and YouTube.

Alkem Laboratories Ltd.

alkemlabs.com

A single idea, which sprouts from a human mind, contains the potential to create marvels that can influence generations. It can redefine rules, it can transform the world. Back in the year 1973, a team of individuals came with such an idea – The idea called Alkem. It was highly potent and resilient, like a spark that could ignite a thousand more ideas. And it did! Looking back at our 4 decade, illustrious journey, that one small idea has Not only triggered us to become one of India’s largest generic and specialty pharmaceutical company but also, create a foothold in over 50 countries 32% of our revenue is generated via offshore sales. As well as we have consistently been ranked amongst the top ten pharmaceutical companies in India. Our portfolio includes illustrious brands like Clavam, Pan, Pan-D and Taxim-O, which feature amongst top 50 pharmaceutical brands in India. For over a decade, our dominance in anti-infective segment has remained unchallenged. We have 21 manufacturing facilities at multiple locations in India and the United States of America. Our upper-crest facilities are inspected and audited as per cGMP guidelines as laid down by leading regulatory authorities such as USFDA, MHRA - UK, SAHPRA-South Africa, TGA - Australia, ANVISA - Brazil, WHO - Geneva, TPD - Health Canada, PPB - Kenya, NDA - Uganda, MOH - Sudan, INVIMA - Colombia, TFDA - Tanzania, Zimbabwe, BfArM-Germany & Other Africa, Asian & CIS Countries. Another feather in our cap was added on December 23rd, 2015, when, Alkem completed it's Initial Public Offering (IPO) and was listed on the Bombay Stock Exchange Limited and the National Stock Exchange of India Limited. Although passion is the fuel that keeps ideas alive, innovation is the catalyst that gives it flight! With over 500 scientists working in 5 global R&D centers, we are empowering innovations that align with our philosophy of ‘Extended Lifecare Beyond Boundaries’.

Catalent

catalent.com

Championing the missions that matter™. Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) and trusted partner to pharma, biotech, and consumer health companies worldwide. We put patients first in everything we do, helping people live better and healthier lives through every product we help develop, manufacture and deliver. With over 1,000 active development programs at any given time, we launch over 100 new products and line extensions annually. Catalent has supported half of all FDA approvals over the past decade, and our teams working at over 40 global sites help us produce over 60 billion doses every year. Our strength lies in our people: teams across our more than 40 sites and thousands of passionate scientists and technicians who bring expertise in development sciences, delivery technologies, and multi-modality manufacturing. What unites us is our commitment to championing our partners’ missions as our own, anticipating customer needs, solving complex challenges and ultimately making a difference in the lives of patients across the globe. At Catalent, you will be able to directly have an impact, solving problems and ensuring excellence for our customers. Our focus on delivering meaningful outcomes alongside our customers means your work directly impacts millions of people around the world. Join us in championing the missions that matter. Catalent is headquartered in Tampa, Florida, with over 40 global sites. Visit www.catalent.com to learn more.

AbbVie

cb abbvie.com

AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.

MANKIND PHARMA LTD

mankindpharma.com

Mankind Pharma, one of the top 5 leading pharmaceutical companies in India, started its journey in 1995. Today, we have an employee base of over 20,000 and are racing towards $1 Billion. At Mankind, we aspire to aid the community in leading a healthy life by formulating, developing, commercializing, and delivering affordable and accessible medicines that satisfy urgent medical needs. We take great pride in the success of our products ranging from Pharma, OTC and FMCG brands like Manforce Condoms, Manforce Tablets, Manforce Staylong Gel, Unwanted 72, Prega News, Gas-O-Fast, Kaloree 1, Kabzend, Acne Star Gel and many others. Our operations are in 34 overseas destinations across Asia, Africa, South-East Asia, Gulf countries and CIS countries. Our Vision - To be a global pharmaceutical company, most admired for its Affordability, Quality and Accessibility of products. Our Mission - To be able to provide cost-effective, innovation based superior quality pharmaceutical products across the globe, to improve the lives of the patients. Mankind strongly believes and follows its Core Values: 𝐂𝐮𝐬𝐭𝐨𝐦𝐞𝐫 𝐂𝐞𝐧𝐭𝐫𝐢𝐜𝐢𝐭𝐲: Commitment to Customer - Internal and External 𝐐𝐮𝐚𝐥𝐢𝐭𝐲: It is in our DNA to maintain and deliver highest quality standards and products 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧: Intensely Research driven organization aiming at product innovation and technology improvements 𝐈𝐧𝐭𝐞𝐠𝐫𝐢𝐭𝐲: Always trustworthy, widely respected to be honest, and believed by everyone 𝐆𝐨 𝐁𝐞𝐲𝐨𝐧𝐝: Aim higher than capabilities 𝐏𝐞𝐨𝐩𝐥𝐞 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐚𝐧𝐝 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧: Together we are foreseeing future and diligently stimulating our people in attaining goals

Lonza

lonza.com

Lonza is a pioneer and world leader in the CDMO industry, setting the pace with cutting-edge science, smart technology, and lean manufacturing. United by a common purpose, we turn our customers’ breakthrough innovations into viable therapies and manufacture the medicines of tomorrow. Founded in Switzerland in 1897, our company is the first and original CDMO, and today we are more dynamic, agile and forward-focused than ever before. As one of the largest Western CDMOs, we bring together a global team of around 18,500 colleagues across five continents to deliver comprehensive, integrated solutions for our customers' complex needs. For our customers and their patients, we bring quality, safety and reliability to bring life-enhancing and life-saving treatments to market at speed and at scale. For our colleagues, we strive to create a sense of belonging and inclusion where every person can thrive and bring their best.

Intas Pharmaceuticals

intaspharma.com

Intas is one of the leading multinational pharmaceutical formulation development, manufacturing, and marketing organization in the world. It has been growing at 19% CAGR and crossed the $2.5 billion mark in the past financial year. The company has set up a network of subsidiaries, under the name Accord Healthcare in the EU, US, Canada, SA, Australia, APAC as well as CIS & MENA regions. Intas is present in 85+ countries, with more than 70% of its revenue coming from global business. Currently ranked 6th in the Indian pharmaceutical market, it’s the largest privately owned Indian generic pharma company. Intas has established leadership in key therapeutic segments like CNS, Cardio, Diabeto, Gastro, Urology, Oncology & Animal Health in India. We are among the top 10 generic players in the highly regulated markets of EU, US & UK. Intas operates 17 advanced formulations, R&D, and distribution facilities, of which 10 are in India and the rest in the UK, Mexico & Greece with the help of our 23,000+ Human Capital. Between them, the facilities are accredited by global regulators such as USFDA, EMA, MHRA, TGA, and others. The company invests ~6-7% of its revenues in R&D and has over 10,000 product registrations worldwide with a strategic pipeline of 300+ high-value FTF/FTM, Biosimilars, and NDDS products. Intas' highly advanced EU-GMP Certified Biopharma division is fueled by a mission to provide affordable “Biosimilars for Billions” across niche segments such as oncology, auto-immune, ophthalmology, nephrology, rheumatology, and hormone-based therapies. The Plasma Fractionation Unit of Intas Pharmaceuticals is a pioneer in manufacturing plasma-derived therapeutics. It houses a full-fledged R&D lab and a state-of-the-art WHO-GMP-certified manufacturing facility complemented with a GLP-compliant QC lab. Our values of Innovation, Customer Delight, Ownership & Collaboration, Performance Focus & Care for Society are the driving forces toward excellence.

Fresenius Kabi

fresenius-kabi.com

As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of critically and chronically ill patients. With over 41,000 employees and present in over 100 countries, Fresenius Kabi’s expansive product portfolio focuses on providing access to high-quality and lifesaving medicines and technologies. In Biopharma, Fresenius Kabi offers cutting-edge biosimilars for autoimmune diseases and oncology. With leading market positions in Medical Nutrition, a broad portfolio of enteral and parenteral products makes a distinct difference in patients’ nutritional status. In MedTech, the company provides vital infusion pumps, cell and gene therapy devices, disposables, and more. Fresenius Kabi is the global leader in supplying blood collection bags and devices, supporting blood banks and healthcare facilities worldwide. The company’s I.V. Generics and Fluids for infusion therapy help save millions of lives every year, in emergency medicine, surgery, oncology, and intensive care. Fresenius Kabi takes a holistic approach to healthcare and uniquely combines experience, expertise, innovation, and dedication – making a difference in the lives of 450 million patients annually. With the #FutureFresenius strategy, the company is developing, producing, and selling new products and technologies and aspires to expand its position as a leading global provider of therapies, improve patient care, generate sustainable value for stakeholders – shaping the future of healthcare. Fresenius Kabi is an operating company of the Fresenius Group, founded in 1912, along with Helios and Quirónsalud. As ONE team, the companies in the Fresenius Group are committed to providing lifesaving and life-changing healthcare solutions on a global scale. User information & community guidelines: https://www.fresenius-kabi.com/social-media-terms-conditions Imprint: www.fresenius-kabi.com/imprint

UCB

cb ucb.com

At UCB, we believe everyone deserves to live the best life they can - as free as possible from the challenges and uncertainty of disease. Our purpose is to support people living with severe central nervous system and immunological conditions by delivering meaningful solutions that go beyond medicine. We are driven by the experiences of patients and caregivers, and inspired to pursue innovations that create real value - not just in clinical outcomes, but in everyday moments, dreams pursued, and simple pleasures enjoyed. Our ambition is to unlock transformative science and technologies that respond to unmet needs and elevate lives. From our headquarters in Belgium to nearly 40 countries around the world, we nurture a culture of respect and care. By listening deeply and collaborating across borders and disciplines, we enable cutting-edge research shaped by patients’ needs. Through strong connections with healthcare professionals, partners, and communities, we strive to make a lasting impact - today and into the future. We're inspired by patients, driven by science.

Loading…

NEWS

Adelphi Group CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

February 10, 2026 08:00 AM

Student accused of AI plagiarism wins lawsuit against Adelphi University

After being accused of cheating, a student sued his university and won. He denied ever having cheating on his essay.

Read Article

November 21, 2024 08:00 AM

Introduction: Attacking the issue

The exciting and ingenious advances we will continue to make in digital technology in the coming decades will revolutionise the way we live...

Read Article

June 22, 2023 07:00 AM

List of victimized companies of MOVEit Cyber Attack

The companies affected by the Move It cyber attack. Stay informed about the latest cybersecurity threats and protect your organization from...

Read Article

May 05, 2020 07:00 AM

Army project aligns data visualization with mental models of cyber defenders

ADELPHI, Md. -- A new data visualization approach developed by researchers working on an Army project may help cybersecurity experts detect,...

Read Article

November 17, 2018 08:00 AM

EY bolsters Advisory practice in Oceania with Adelphi Digital acquisition

Professional services firm EY has acquired Adelphi Digital Consulting Group, a digital consultancy with around 170 employees based in Australia, Singapore and...

Read Article

November 17, 2018 08:00 AM

EY buys Adelphi, adds 170 staff in Australia, Singapore and Thailand

EY, one of the globe's four largest accounting and consulting groups, has beefed up its digital consultancy offering in Asia Pacific (APAC)...

Read Article

September 06, 2018 07:00 AM

Army research takes proactive approach to defending computer systems

ADELPHI, Md. -- A team of researchers from the U.S. Army Research Laboratory, the University of Canterbury in New Zealand and the Gwangju...

Read Article

August 26, 2018 07:00 AM

Evita Almassi, Christopher Main (Published 2018)

The bride, a digital marketing and communications manager, and the groom, a cybersecurity analyst, met through OkCupid in 2014.

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-96680

SUMMARY

A vulnerability was detected in ByteDance Coze Scraper Extension up to 2.0.2. Affected by this vulnerability is the function chrome.runtime.onMessageExternal.addListener of the file static/background/index.js of the component External Message Handler. The manipulation of the argument body.url/paginationConfig/xPathConfig/body.urls/xPaths results in missing authorization. The attack can be launched remotely. The exploit is now public and may be used. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-09-23

Updated

Date2026-09-23

RISK INFORMATION (Score: 4.3)

cvss2

Base Score: 5.0

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:N/A:N

cvss3

Base Score: 4.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:N/A:N

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

2.8

REFERENCES

CVE-2026-96678

SUMMARY

A security vulnerability has been detected in weiqingwen spring-boot-forum up to 538eecc3c6b85fdf0768ab4e8354b48c0c17d94f. Affected is the function validate of the file src/main/java/com/qingwenwei/util/NewUserFormValidator.java of the component Avatar Upload. The manipulation of the argument Username leads to path traversal. The attack can be initiated remotely. The exploit has been disclosed publicly and may be used. Continious delivery with rolling releases is used by this product. Therefore, no version details of affected nor updated releases are available. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-09-23

Updated

Date2026-09-23

RISK INFORMATION (Score: 6.3)

cvss2

Base Score: 6.5

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 6.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.8

REFERENCES

CVE-2026-96676

SUMMARY

A vulnerability was identified in Fast FAC1900R 20190827_2.0.2. The impacted element is the function get_alias_name of the component uhttpd. Such manipulation leads to stack-based buffer overflow. The attack may be performed from remote. The exploit is publicly available and might be used. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-09-23

Updated

Date2026-09-23

RISK INFORMATION (Score: 6.3)

cvss2

Base Score: 6.5

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 6.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.8

REFERENCES

CVE-2026-96606

SUMMARY

A security flaw has been discovered in LB-Link BL-CPE600EU 5.8.13. This vulnerability affects unknown code of the file Mifi_config.bin of the component Configuration Backup Handler. The manipulation results in information disclosure. The attack can be launched remotely. The exploit has been released to the public and may be used for attacks. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-09-23

Updated

Date2026-09-23

RISK INFORMATION (Score: 5.3)

cvss2

Base Score: 5.0

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:N/A:N

cvss3

Base Score: 5.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N

cvss4

Base Score: 5.5

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

3.9

REFERENCES

CVE-2026-70125

SUMMARY

Microsoft Outlook Remote Code Execution Vulnerability

Published

Date2026-09-23

Updated

Date2026-09-23

RISK INFORMATION (Score: 8.8)

cvss3

Base Score: 8.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

2.8

REFERENCES

https://msrc.microsoft.com/update-guide/vulnerability/CVE-2026-70125

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

Adelphi Group Vendor Cyber Rating & Cyber Score

Adelphi Group A.I CyberSecurity Scoring

Adelphi Group CyberSecurity News & History

Adelphi Group Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for Adelphi Group

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types Adelphi Group vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - Adelphi Group (X = Date, Y = Severity)

Adelphi Group Subsidiaries

Adelphi Group

Adelphi Group Similar Companies

MSD

Alkem Laboratories Ltd.

Catalent

AbbVie

MANKIND PHARMA LTD

Lonza

Intas Pharmaceuticals

Fresenius Kabi

UCB

Adelphi Group CyberSecurity News

Student accused of AI plagiarism wins lawsuit against Adelphi University

Introduction: Attacking the issue

List of victimized companies of MOVEit Cyber Attack

Army project aligns data visualization with mental models of cyber defenders

EY bolsters Advisory practice in Oceania with Adelphi Digital acquisition

EY buys Adelphi, adds 170 staff in Australia, Singapore and Thailand

Army research takes proactive approach to defending computer systems

Evita Almassi, Christopher Main (Published 2018)

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

Adelphi Group CyberSecurity News & History

Adelphi Group Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for Adelphi Group

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types Adelphi Group vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - Adelphi Group (X = Date, Y = Severity)

Adelphi Group Subsidiaries

Adelphi Group

Adelphi Group Similar Companies

MSD

Alkem Laboratories Ltd.

Catalent

AbbVie

MANKIND PHARMA LTD

Lonza

Intas Pharmaceuticals

Fresenius Kabi

UCB

Adelphi Group CyberSecurity News

Student accused of AI plagiarism wins lawsuit against Adelphi University

Introduction: Attacking the issue

List of victimized companies of MOVEit Cyber Attack

Army project aligns data visualization with mental models of cyber defenders

EY bolsters Advisory practice in Oceania with Adelphi Digital acquisition

EY buys Adelphi, adds 170 staff in Australia, Singapore and Thailand

Army research takes proactive approach to defending computer systems

Evita Almassi, Christopher Main (Published 2018)

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo